Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
New England Journal of Medicine · 12.03.2026 · 394 (11) · 1061-1073
DOI: 10.1056/nejmoa2511882 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 12.03.2026. Verfasst von Hanny Al-Samkari und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Classical Hematology, Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Gastrointestinal Neoplasms, Receptors, Fc, Recombinant Fusion Proteins. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Amgen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Classical Hematology, Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston.
- Medical Oncology, Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid.
- Facultad HM de Ciencias de la Salud de la Universidad Camilo José Cela, Madrid.
- Instituto de Investigación Sanitaria HM Hospitales, Madrid.
- Department of Medical Oncology, Gaziosmanpaşa Medical Park Hospital, Istanbul, Turkey.
- Department of Internal Medicine, İstinye University Faculty of Medicine, Istanbul, Turkey.
ORCID-Profile: Hanny Al-Samkari
Förderung
- Amgen
Zitieren
APA
Al-Samkari, H., Muñoz, C., Geredeli, Ç., Korantzis, I., González Astorga, B., Arslan, C., Cordeiro Camargo, J. F., Scotté, F., Borges, G., Wang, K., Eisen, M., Kuter, D. J., & Soff, G. A. (2026). Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia. New England Journal of Medicine, 394(11), 1061-1073. https://doi.org/10.1056/nejmoa2511882
Vancouver
Al-Samkari H, Muñoz C, Geredeli Ç, Korantzis I, González Astorga B, Arslan C, et al. Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia. New England Journal of Medicine. 2026;394(11):1061-1073. doi:10.1056/nejmoa2511882
BibTeX
@article{AlSamkari2026,
author = {Al-Samkari, Hanny and Muñoz, César and Geredeli, Çağlayan and Korantzis, Ippokratis and González Astorga, Beatriz and Arslan, Cagatay and Cordeiro Camargo, Johnny Francisco and Scotté, Florian and Borges, Giuliano and Wang, Kejia and Eisen, Melissa and Kuter, David J and Soff, Gerald A},
title = {Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {11},
pages = {1061--1073},
doi = {10.1056/nejmoa2511882}
}
EUVIMED